Morphine Market

  • Published on 2025-11-05
  • Report Code: 985
  • 170-350 pages
Morphine Market

Morphine Market: Segmented: by application (Pain Management, Cancer Pain, Neuropathic Pain, Osteoarthritis Pain, Other Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant); by Routine (Oral, Injectables); , And Region - Global Analysis Of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031

Table Of Content

Contents          

  1. Executive Summary
  2. Global Morphine Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Morphine Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Morphine Market
    1. Market Size & forecast, 2020A-2031F
      1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
      2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
  12. Global Morphine Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F  
  13. By application: Market Share (2020-2031F)
    1. Pain Management, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    2. Cancer Pain, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    3. Neuropathic Pain, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    4. Osteoarthritis Pain, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    5. Other Pain Management, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    6. Diarrhea Suppressant, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    7. Cold and Cough Suppressant, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
  14. By routine: Market Share (2020-2031F)
    1. Oral By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
    2. Injectables, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
  15. Company Profile    
    1. Alcaliber S.A
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Pfizer Inc.
    3. Sun Pharmaceutical Industries Ltd.
    4. Taj Pharmaceuticals Limited
    5. MANUS AKTTEVA BIOPHARMA LLP
    6. Mallinckrodt Pharmaceuticals
    7. Purdue Pharma L.P.
    8. Johnson Matthey Fine Chemicals
    9. Verve Health Care Ltd.
    10. NORTHEAST PHARM
    11. Other Prominent Players

Consultant Recommendation

The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients